Joseph Stich
Oficial de Recursos Humanos en SURMODICS, INC. .
Fortuna: 2 M $ al 30/04/2024
Perfil
Joseph J.
Stich's current job(s) include Senior Vice President-Human Resources at Surmodics, Inc. since 2010 and Vice President & General Manager at In Vitro Diagnostics since 2011.
Mr. Stich's former job(s) include Vice President-Sales & Business Development at MGI PHARMA, Inc. from 2005 to 2009, Vice President-Corporate Development at Abraxis BioScience, Inc. from 2009 to 2010, and President & Chief Operating Officer at Pharmaceutical Corp.
of America.
Mr. Stich's education history includes an MBA from Rockhurst University in 1996 and an undergraduate degree from the University of Wisconsin-Whitewater in 1988.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
SURMODICS, INC.
0.43% | 04/12/2023 | 61 796 ( 0.43% ) | 2 M $ | 30/04/2024 |
Cargos activos de Joseph Stich
Empresas | Cargo | Inicio |
---|---|---|
SURMODICS, INC. | Oficial de Recursos Humanos | 01/04/2020 |
In Vitro Diagnostics
In Vitro Diagnostics Medical SpecialtiesHealth Technology Part of Siemens AG, In Vitro Diagnostics is a medical diagnostic testing American company. The company is located in the US. The company was founded in 1986. In Vitro Diagnostics was acquired by Dade Behring Holdings, Inc. from EIDP, Inc. on May 08, 1996 for $450 million. | Corporate Officer/Principal | 01/08/2011 |
Antiguos cargos conocidos de Joseph Stich.
Empresas | Cargo | Fin |
---|---|---|
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 01/01/2010 |
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Ventas & Marketing | 01/01/2009 |
Pharmaceutical Corp. of America | Presidente | - |
Formación de Joseph Stich.
Rockhurst University | Masters Business Admin |
University of Wisconsin-Whitewater | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
SURMODICS, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
Pharmaceutical Corp. of America | |
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
In Vitro Diagnostics
In Vitro Diagnostics Medical SpecialtiesHealth Technology Part of Siemens AG, In Vitro Diagnostics is a medical diagnostic testing American company. The company is located in the US. The company was founded in 1986. In Vitro Diagnostics was acquired by Dade Behring Holdings, Inc. from EIDP, Inc. on May 08, 1996 for $450 million. | Health Technology |
- Bolsa de valores
- Insiders
- Joseph Stich